Recognizing that Evidence is Made, not Born

Therapeutic product development, licensing and reimbursement may seem a well‐oiled machine, but continuing high attrition rates, regulatory refusals, and patients’ access issues suggest otherwise; despite serious efforts, gaps persist between stakeholders’ stated evidence requirements and actual evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Robyn, Lee, David K., Sabourin, Pierre, Ferguson, John, Metcalf, Marilyn, Smith, Meredith, Corriol‐Rohou, Solange, Eichler, Hans‐Georg, Lumpkin, Murray, Hirsch, Gigi, Chen, Inhua Muijrers, O'Rourke, Brian, Schiel, Anja, Crabb, Nick, Aronson, Naomi, Pezalla, Edmund, Boutin, Marc, Binder, Louise, Wilhelm, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590384/
https://www.ncbi.nlm.nih.gov/pubmed/30472743
http://dx.doi.org/10.1002/cpt.1317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590384/
https://www.ncbi.nlm.nih.gov/pubmed/30472743
http://dx.doi.org/10.1002/cpt.1317

Ejemplares similares